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assignment of the wild-type BlaP (BlaP-WT) and of the two 
reference proteins, BlaP197Q0 and BlaP216Q0, wherein a 
Pro-Gly dipeptide has been introduced at position 197 and 
216, respectively; this dipeptide originates from the addi-
tion of the Sma1 restriction site at the genetic level to allow 
further polyQ sequence insertion.
Keywords BlaP hybrid proteins · Polyglutamine model 
proteins · Protein aggregation · Polyglutamine diseases · 
Resonance assignment
Biological context
Polyglutamine (polyQ) diseases, including the well-known 
Huntington’s disease and several spinocerebellar ataxias, are 
progressive and inherited neurodegenerative disorders asso-
ciated with neural proteins that contain an ‘expanded’ polyQ 
sequence encoded by CAG trinucleotides repeats (Hands and 
Wyttenbach 2010). CAG repeats are present in the genes 
Abstract Class A β-lactamases have been widely used as 
versatile scaffolds to create hybrid (or chimeric) proteins 
for a series of applications ranging from basic research 
to medicine. We have, in particular, used the β-lactamase 
BlaP from Bacillus licheniformis 749/C (BlaP) as a protein 
scaffold to create model polyglutamine (polyQ) proteins in 
order to better understand the mechanism(s) by which an 
expanded polyQ sequence triggers the formation of amyloid 
fibrils. The model chimeras were designed by inserting a 
polyQ sequence of various lengths at two different locations 
within BlaP (i.e. position 197 or position 216) allowing a 
detailed comparison of the effects of subtle differences in 
the environment of the polyQ sequence on its ability to trig-
ger protein aggregation. In order to investigate the effects 
of the polyQ insertion at both positions on the structure, 
stability and dynamics of BlaP, a series of NMR experi-
ments including H/D exchange are foreseen. Accordingly, 
as necessitated by these studies, here we report the NMR 
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of even healthy people; however, the former is inherently 
unstable and tends to expand in successive generations by 
mutations leading to an increasingly long polyQ sequence. 
When the length of this polyQ sequence exceeds a threshold 
characteristic to each disease (generally comprised between 
35 and 45 glutamines), it becomes pathogenic by facilitating 
the aggregation and conversion of the polyQ protein into 
amyloid fibrils which are deposited in neurons as nuclear 
inclusions (Orr and Zoghbi 2007; Almeida et al. 2013). Pro-
teins involved in polyQ diseases have very little in common 
at the level of sequence, structure or function, except for the 
presence of the expanded polyQ sequence which is the criti-
cal determinant for their amyloid fibril-forming propensity 
(Almeida et al. 2013). It has been shown that non-polyQ 
regions (i.e. folded domains and/or sequences flanking the 
polyQ tract) play an important modulating role, either facili-
tative or preventive, in the aggregation process (Robertson 
and Bottomley 2010). The underlying principles of how non-
polyQ regions influence polyQ sequences and their ability 
to induce protein aggregation are not yet fully understood. 
Disease-associated polyQ proteins cannot be easily handled 
in vitro due to their large size and/or poor solubility; there-
fore an alternative strategy to better understand these princi-
ples involves the development and characterization of model 
polyQ proteins whereby a polyQ sequence is inserted into a 
well-characterized, soluble and easy to handle host protein.
We engineered polyQ model proteins using the 
β-lactamase from Bacillus licheniformis 749/C referred to as 
BlaP. BlaP has been chosen as a protein scaffold because: (i) 
it is a relatively small and stable protein (~ 30 kDa), readily 
overexpressed in E.coli (Huynen et al. 2013); (ii) its three-
dimensional structure is well-characterized: the protein is 
composed of two structural domains (an α domain and an 
α/β domain) at the interface of which the catalytic site is 
located; and most importantly, (iii) it tolerates peptide inser-
tions at several positions (Vandevenne et al. 2007; Scarafone 
et al. 2012; Huynen et al. 2013).
BlaP polyQ-chimeras were created by inserting a polyQ 
sequence of different lengths (from 23Q to 79Q) at two 
locations of BlaP, i.e. at position 197 (168) and 216 (187), 
referred to as 197 and 216 chimeras, respectively. Note that 
these position numbers correspond to those of standard 
numbering scheme defined for class A β-lactamases, ABL 
(Ambler et al. 1991); the underlined number appearing here 
in parentheses corresponds to the number in BlaP sequence. 
The correspondence between the two numbering systems 
is given in Table 1. The ABL numbering has been previ-
ously used to describe the characterization of BlaP-based 
hybrid proteins (Vandevenne et al. 2007; Scarafone et al. 
2012; Huynen et al. 2013, 2015) and is therefore used here 
in the introduction and methods sections; in the remainder 
of the paper dealing with NMR, only the sequence number 
(underlined number) will be used. Note also that the BlaP 
protein used to create the polyQ chimeras is the secreted 
form following complete N-terminal proteolytic process-
ing and therefore starting at position 27 (Vandevenne et al. 
2007) (Table 1).
These two insertion sites were selected based on the fol-
lowing: (i) both sites correspond to permissive insertion sites, 
e.g. insertion of peptide of various lengths at these positions 
results in chimeric BlaP proteins that are soluble and func-
tional (Vandevenne et al. 2007); (ii) both sites are located 
in solvent-exposed loops of similar size (4 residues for the 
197 loop versus 5 residues for the 216 loop) connecting two 
α-helices, therefore they have a comparable overall protein 
context; (iii) while position 197 is situated in a loop within the 
α-domain, the loop containing position 216 links the α and α/β 
domains. This distinction allows us to compare the effects of 
an intradomain (i.e. at position 197) versus those of an inter-
domain (i.e. at position 216) insertion of a polyQ sequence on 
the properties of the host protein.
To insert poly(CAG) sequences within the β-lactamase 
gene, recognition sites for the Sma1 restriction enzyme have 
been introduced at the location of the insertion (i.e. between 
sequences coding for the amino acids 197–198 or 216–217) 
(Scarafone et al. 2012; Thorn et al. in preparation) (Table 1). 
The insertion of this restriction site at the gene level leads to 
translation of the dipeptide proline-glycine at position 197 and 
216 respectively; these proteins are referred to as BlaP197Q0 
and BlaP216Q0. By comparison with these two BlaP variants 
with a Pro-Gly dipeptide inserted at these two positions, we 
aim to distinguish between the impact of the polyQ repeat and 
insertions in general.
The aggregation properties of the BlaP polyQ-chimeras 
are characteristic of proteins associated with polyQ diseases 
(Scarafone et al. 2012; Thorn et al. in preparation); namely: (i) 
there is a Q-threshold length above which the polyQ sequence 
triggers the aggregation of proteins into amyloid fibrils, and 
(ii) above this threshold, the longer the polyQ sequence, the 
faster the aggregation. Moreover, the aggregation propensity 
of BlaP-polyQ chimeras depends on the location of the polyQ 
sequence within BlaP. Interestingly, the 216 chimeras display 
increased aggregation propensity: indeed (i) the minimum 
polyQ length leading to aggregation is lower compared to 197 
chimeras, and (ii) above threshold length, the aggregation rate 
is significantly higher than that observed by 197 chimeras with 
equivalent polyQ lengths. This observation suggests a signifi-
cant modulating role of the non-polyQ regions (i.e. the BlaP 
moiety) on the mechanism of aggregation induced by polyQ 
sequences. Altogether, these results indicate that BlaP-polyQ 
chimeras are relevant protein models to further investigate (i) 
how expanded polyQ sequences trigger the aggregation of pro-
teins into amyloid fibrils and (ii) how non-polyQ regions mod-
ulate the propensity of polyQ sequences to induce aggregation. 
The latter may depend on the (local) stability and dynamics 
of the BlaP moiety within each polyQ chimera; experiments 
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such as H/D exchange monitored by NMR are therefore of 
particular interest. Such work requires the assignment of the 
 [1H-15N] 2D HSQC spectrum of the BlaP chimeras. Here, we 
report the NMR assignment of the wild-type BlaP (BlaP-WT) 
and of the two reference proteins, BlaP197Q0 and BlaP216Q0.
Methods and experiments
Molecular biology
The gene coding for BlaP-WT, BlaP197Q0 and BlaP216Q0 
were amplified from the pNYBlaP-WT, pNYBlaP197Q0 and 
pNYBlaP216Q0 vectors, respectively (Scarafone et al. 2012; 
Huynen et al. 2015), with the following primers: 5′-ACA 
ATT CCC CTC TAG AAA TAA TTT TGT TTA ACT TTA AGA 
AGG AGA TAT ACC ATG ACG GAG ATG AAA GAT GAT 
TTT GCA AAAC-3′ and 5′-GAC GGC CAG TGA ATT CTC 
AGT GGT GGT GGT GGT GGG GCC CTT TCC CGT TCA 
TGT TTA AGG C-3′. The resulting DNA was then cloned into 
the pET28b vector containing a kanamycin resistance gene 
and for which protein expression is inducible by isopropyl 
β-D-1-thiogalactopyranoside (IPTG) using T7 promoter. 
In this vector, the BlaP gene is followed by a C-terminal 
poly(His)5 tag to facilitate the purification of the protein. A 
SmaI restriction site has also been introduced into the BlaP 
variant gene between the trinucleotides coding for residues 
197–198 (168–169) or 216–217 (187–188); this restric-
tion site is translated into a Pro-Gly dipeptide at position 
197–198 (168–169) or 216–217 (187–188) of the protein 
respectively. The sequence of the three genes cloned into 
the pET28b vector was checked by the Sanger method at 
the GIGA GenoTranscriptomics technology platform (Liège, 
Belgium). These vectors were then used to transform the 
BL21(DE3) expression strain of E. coli (Novagen, WI, 
USA).
Expression and purification of 15N and 13C double‑labeled 
BlaP and its variants
BlaP-WT and its PG-inserted variants were expressed in E. 
coli BL21 (DE3) cells and uniformly labeled with 15N and 
13C. Firstly, cells were grown in 2 L of LB medium contain-
ing 50 µg/mL kanamycin at 37 °C under orbital agitation 
at 250 rpm until the absorbency at 600 nm reached ≈0.7. 
Cultures were then centrifuged at 2800 g for 5 min (Avanti 
J-E Centrifuge, Beckman Coulter). Supernatants were dis-
carded and the pellets were resuspended in 500 mL of M9 
minimal medium containing 50 µg/mL kanamycin, 2 g 
13C-d-glucose and 0.5 g 15N-NH4Cl as carbon and nitrogen 
sources, respectively (Cambridge Isotope Laboratory, Ando-
ver, USA). After 1 h of incubation at 37 °C under orbital 
agitation at 250 rpm, protein expression was induced with 
1.2 mM IPTG (final concentration). Cell growth was then 
allowed for a further 3 h of incubation. Cells were harvested 
by centrifugation (1400 g for 15 min, Avanti J-E Centri-
fuge, Beckman Coulter) and then resuspended in 100 mL 
phosphate buffered saline (PBS, 50 mM sodium phosphate, 
150 mM NaCl, pH 7.5) containing 2 µL benzonase (Nova-
gen), 2 mM  MgCl2 and 2 tablets of EDTA-free, protease-
inhibitor cocktail (cOmplete™, Roche, Penzberg, Germany). 
Cells were homogenized using an Ultra-turax homogenizer 
(IKA T18 basic, VWR, Radnor, Pennsylvania) and lysed 
by three passages through a French press (Emulsiflex-C3, 
Avestin, Ottawa) at 1000–1500 bar. The cytoplasmic extract 
obtained was then centrifuged at 2600 g for 30 min (Avanti 
J-E Centrifuge, Beckman Coulter) and the supernatant suc-
cessively filtered through a 0.7 and 0.45 µm cut-off pore 
membrane. BlaP-WT and its variants were purified by nickel 
affinity chromatography as previously described (Scarafone 
et al. 2012). Fractions of elution containing more than 95% 
of proteins of interest, as assessed by SDS–PAGE and den-
sitometry analysis, were pooled and dialyzed twice against 
15 L of 20 mM sodium phosphate, 50 mM NaCl, pH 6.5. 
The protein concentration was determined by measuring the 
absorbance at 280 nm using a molar extinction coefficient 
value of 33,000 M− 1 cm− 1 (Scarafone et al. 2012) and pro-
teins were stored at −20 °C.
NMR spectroscopy
NMR experiments were acquired at 308 K using 15N-13C 
double-labeled protein concentrated to 500–800  µM in 
20 mM sodium phosphate, 50 mM NaCl, pH 6.5, with 
added 5%  D2O and 0.2% of DSS. 1H, 13C and 15N backbone 
resonance assignments for BlaP197Q0 and BlaP216Q0 were 
determined from  [1H-15N] 2D BEST-TROSY HSQC spectra 
and standard 3D TROSY triple resonance NMR experiments 
(including HNCA, HN(CO)CA, HNCACB, HN(CO)CACB, 
HNCO, and HN(CA)CO) acquired on a 900 MHz Bruker 
spectrometer equipped with a 5-mm cryogenic triple-res-
onance probe (Biomolecular Magnetic Resonance Center, 
Goethe University of Frankfurt). Backbone resonance 
assignments for BlaP-WT were determined from  [1H-15N] 
2D HSQC spectrum and 3D NMR experiments (i.e. HNCA 
and HN(CO)CA) acquired on a 500 MHz Bruker spectrom-
eter equipped with a 5-mm cryogenic triple-resonance probe 
(Centre de REsonance MAgnétique Nucléaire, University of 
Liège). Data of BlaP-WT and BlaP197Q0 were processed 
using Topspin (version 2.1, Bruker BioSpin GmbH, Ger-
many) and analyzed using CCPNMR (Vranken et al. 2005). 
Data for BlaP216Q0 were processed using NMRPipe (Dela-
glio et al. 1995) and analyzed using Sparky (T. D. Goddard 
and D. G. Kneller, SPARKY 3, University of California, San 
Francisco). All NMR spectra were referenced by assigning 
to 0 ppm the hydrogen frequency of DSS and using the indi-
rect referencing method described by Wishart et al. (1995).
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Table 1  Correspondence between the standard numbering scheme 
defined for class A β-lactamases (Ambler et al. 1991) and the number 
in BlaP sequence as well as that of BlaP variants. First column, list of 
residues; ABL, number according to the standard numbering scheme 
defined for class  A β-lactamase; WT, Blap-WT; 197, Blap197Q0; 
216, Blap216Q0. The position of the two insertion sites is framed and 
residue numbers are underlined when they differ from that of Blap-
WT
ABL WT 197 216
T 27 1 1 1
E 28 2 2 2
M 29 3 3 3
K 30 4 4 4
D 31 5 5 5
D 32 6 6 6
F 33 7 7 7
A 34 8 8 8
K 35 9 9 9
L 36 10 10 10
E 37 11 11 11
E 38 12 12 12
Q 39 13 13 13
F 40 14 14 14
D 41 15 15 15
A 42 16 16 16
K 43 17 17 17
L 44 18 18 18
G 45 19 19 19
I 46 20 20 20
F 47 21 21 21
A 48 22 22 22
L 49 23 23 23
D 50 24 24 24
T 51 25 25 25
G 52 26 26 26
T 53 27 27 27
N 54 28 28 28
R 55 29 29 29
T 56 30 30 30
V 57 31 31 31
A 59 32 32 32
Y 60 33 33 33
R 61 34 34 34
P 62 35 35 35
D 63 36 36 36
E 64 37 37 37
R 65 38 38 38
F 66 39 39 39
A 67 40 40 40
F 68 41 41 41
A 69 42 42 42
S 70 43 43 43
T 71 44 44 44
I 72 45 45 45
K 73 46 46 46
A 74 47 47 47
L 75 48 48 48
T 76 49 49 49
V 77 50 50 50
G 78 51 51 51
V 79 52 52 52
L 80 53 53 53
L 81 54 54 54
Q 82 55 55 55
ABL WT 197 216
Q 83 56 56 56
K 86 57 57 57
S 87 58 58 58
I 88 59 59 59
E 89 60 60 60
D 90 61 61 61
L 91 62 62 62
N 92 63 63 63
Q 93 64 64 64
R 94 65 65 65
I 95 66 66 66
T 96 67 67 67
Y 97 68 68 68
T 98 69 69 69
R 99 70 70 70
D 100 71 71 71
D 101 72 72 72
L 102 73 73 73
V 103 74 74 74
N 104 75 75 75
Y 105 76 76 76
N 106 77 77 77
P 107 78 78 78
I 108 79 79 79
T 109 80 80 80
E 110 81 81 81
K 111 82 82 82
H 112 83 83 83
V 113 84 84 84
D 114 85 85 85
T 115 86 86 86
G 116 87 87 87
M 117 88 88 88
T 118 89 89 89
L 119 90 90 90
K 120 91 91 91
E 121 92 92 92
L 122 93 93 93
A 123 94 94 94
D 124 95 95 95
A 125 96 96 96
S 126 97 97 97
L 127 98 98 98
R 128 99 99 99
Y 129 100 100 100
S 130 101 101 101
D 131 102 102 102
N 132 103 103 103
A 133 104 104 104
A 134 105 105 105
Q 135 106 106 106
N 136 107 107 107
L 137 108 108 108
I 138 109 109 109
L 139 110 110 110
ABL WT 197 216
K 140 111 111 111
Q 141 112 112 112
I 142 113 113 113
G 143 114 114 114
G 144 115 115 115
P 145 116 116 116
E 146 117 117 117
S 147 118 118 118
L 148 119 119 119
K 149 120 120 120
K 150 121 121 121
E 151 122 122 122
L 152 123 123 123
R 153 124 124 124
K 154 125 125 125
I 155 126 126 126
G 156 127 127 127
D 157 128 128 128
E 158 129 129 129
V 159 130 130 130
T 160 131 131 131
N 161 132 132 132
P 162 133 133 133
E 163 134 134 134
R 164 135 135 135
F 165 136 136 136
E 166 137 137 137
P 167 138 138 138
E 168 139 139 139
L 169 140 140 140
N 170 141 141 141
E 171 142 142 142
V 172 143 143 143
N 173 144 144 144
P 174 145 145 145
G 175 146 146 146
E 176 147 147 147
T 177 148 148 148
Q 178 149 149 149
D 179 150 150 150
T 180 151 151 151
S 181 152 152 152
T 182 153 153 153
A 183 154 154 154
R 184 155 155 155
A 185 156 156 156
L 186 157 157 157
V 187 158 158 158
T 188 159 159 159
S 189 160 160 160
L 190 161 161 161
R 191 162 162 162
A 192 163 163 163
F 193 164 164 164
A 194 165 165 165
1H, 13C and 15N backbone resonance assignments of the β-lactamase BlaP from Bacillus…
1 3
Extent of assignment and data deposition
BlaP-WT comprises 265 residues (excluding the poly(His)5 
tag and the preceding proline residue introduced with the 
tag), while the BlaP197Q0 and BlaP216Q0 variants are 
composed of 267 residues due to the addition of the Pro-
Gly dipeptide (Table 1). Despite the size of the proteins 
(30 kDa), the HSQC spectra of the three proteins are well-
dispersed owing to their folded structure and α/β content.
BlaP-WT
Figure 1 shows the  [1H-15N] 2D HSQC spectrum of BlaP-
WT. A total of 98.8% (excluding the 11 prolines) of the 
expected backbone 1H-15N correlations were assigned; cor-
responding to 251 out of 254 residues. Moreover, 94.4% of 
the  Cα were assigned. Missing assignments (i.e. residues for 
which no corresponding resonance was observed) include 
the two first residues belonging to the N-terminus (T1 & 
E2) and A208. The chemical shift assignments for BlaP-WT 
have been deposited in the BioMagResBank (http://www.
bmrb.wisc.edu) under the accession number 25821.
BlaP197Q0
Figure  2 shows the  [1H-15N] 2D HSQC spectrum of 
BlaP197Q0. A total of 95.3% of the ‘assignable’ backbone 
1H-15N correlations (i.e. excluding the 12 prolines) were 
assigned; corresponding to 243 out of 255 residues. Moreo-
ver 95.1%  Cα, 95.2%  Cβ and 95.1%  C’ were also assigned. 
Missing assignments include the two residues belonging to 
the N-terminus (T1 & E2), A163, A165, all residues jux-
taposing the insertion site D168 from E167 to L172 inclu-
sive, A210 and D242. The chemical shift assignments for 
BlaP197Q0 have been deposited in the BioMagResBank 
Table 1  (continued)
ABL WT 197 216
L 195 166 166 166
E 196 167 167 167
D 197 168 168 168
P 169
G 170
K 198 169 171 169
L 199 170 172 170
P 200 171 173 171
S 201 172 174 172
E 202 173 175 173
K 203 174 176 174
R 204 175 177 175
E 205 176 178 176
L 206 177 179 177
L 207 178 180 178
I 208 179 181 179
D 209 180 182 180
W 210 181 183 181
M 211 182 184 182
K 212 183 185 183
R 213 184 186 184
N 214 185 187 185
T 215 186 188 186
T 216 187 189 187
P 188
G 189
G 217 188 190 190
D 218 189 191 191
A 219 190 192 192
L 220 191 193 193
I 221 192 194 194
R 222 193 195 195
A 223 194 196 196
G 224 195 197 197
V 225 196 198 198
ABL WT 197 216
P 226 197 199 199
D 227 198 200 200
G 228 199 201 201
W 229 200 202 202
E 230 201 203 203
V 231 202 204 204
A 232 203 205 205
D 233 204 206 206
K 234 205 207 207
T 235 206 208 208
G 236 207 209 209
A 237 208 210 210
A 238 209 211 211
S 240 210 212 212
Y 241 211 213 213
G 242 212 214 214
T 243 213 215 215
R 244 214 216 216
N 245 215 217 217
D 246 216 218 218
I 247 217 219 219
A 248 218 220 220
I 249 219 221 221
I 250 220 222 222
W 251 221 223 223
P 252 222 224 224
P 254 223 225 225
K 255 224 226 226
G 256 225 227 227
D 257 226 228 228
P 258 227 229 229
V 259 228 230 230
V 260 229 231 231
L 261 230 232 232
A 262 231 233 233
ABL WT 197 216
V 263 232 234 234
L 264 233 235 235
S 265 234 236 236
S 266 235 237 237
R 267 236 238 238
D 268 237 239 239
K 269 238 240 240
K 270 239 241 241
D 271 240 242 242
A 272 241 243 243
K 273 242 244 244
Y 274 243 245 245
D 275 244 246 246
D 276 245 247 247
K 277 246 248 248
L 278 247 249 249
I 279 248 250 250
A 280 249 251 251
E 281 250 252 252
A 282 251 253 253
T 283 252 254 254
K 284 253 255 255
V 285 254 256 256
V 286 255 257 257
M 287 256 258 258
K 288 257 259 259
A 289 258 260 260
L 290 259 261 261
N 291 260 262 262
M 292 261 263 263
N 293 262 264 264
G 294 263 265 265
K 295 264 266 266
G 296 265 267 267
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Fig. 1  a 500 MHz  [1H-15N] 
2D HSQC spectrum of 15N-
13C double-labeled BlaP-WT 
in 20 mM phosphate buffer, 
50 mM NaCl, 5% D20 and 
0.2% DSS at pH 6.5 and 308K. 
b Magnified view of central, 
clustered region of spectrum
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Fig. 2  a 900 MHz  [1H-15N] 
2D BEST-TROSY HSQC 
spectrum of 15N-13C double-
labeled BlaP197Q0 in 20 mM 
phosphate buffer, 50 mM NaCl, 
5% D20 and 0.2% DSS at pH 
6.5 and 308K. b Magnified view 
of central, clustered region of 
spectrum
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Fig. 3  a 900 MHz  [1H-15N] 
2D BEST-TROSY HSQC 
spectrum of 15N-13C double-
labeled BlaP216Q0 in 20 mM 
phosphate buffer, 50 mM NaCl, 
5% D20 and 0.2% DSS at pH 
6.5 and 308K. b Magnified view 
of central, clustered region of 
spectrum
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(http://www.bmrb.wisc.edu) under the accession number 
19976.
BlaP216Q0
Figure  3 shows the  [1H-15N] 2D HSQC spectrum of 
BlaP216Q0. A total of 98.4% of the ‘assignable’ back-
bone 1H-15N correlations were assigned; corresponding 
to 251 out of 255 residues. Moreover 98.5%  Cα, 98.4%  Cβ 
and 92.9%  C’ were also assigned. Missing assignments 
include the first residues belonging to the N-terminus (T1 
& E2), R195 and D242. In contrast with the BlaP197Q0 
assignment, it was possible to assign residues juxtaposing 
the insertion site T187. The chemical shift assignments for 
BlaP216Q0 have been deposited in the BioMagResBank 
(http://www.bmrb.wisc.edu) under the accession number 
25003.
For all three proteins, the backbone amides belonging 
to the two N-terminal residues (i.e. T1 & E2) were not 
observed due to rapid hydrogen exchange with the sol-
vent at neutral pH (Bundi and Wüthrich 1977). Likewise, 
complete backbone assignment in the flexible and exposed 
intradomain loop encompassing the 168 insertion site (i.e. 
between α-helices 8 and 9) was challenging, particularly 
following dipeptide (Pro-Gly) insertion at this site, as 
suggested by the high number of missing assignments in 
BlaP197Q0 within this region, i.e. residues E167 to L172. 
Interestingly, it was possible to assign residues on the 
interdomain loop encompassing the 187 insertion site even 
after dipeptide insertion. Signals for residues E167-L172 
are likely too broadened to be observed due to an unfa-
vourable intermediate exchange regime. On the contrary, 
residues juxtaposing the 187 insertion site in BlaP216Q0, 
e.g. residues T187 to G190, are readily observed in the 
HSQC spectrum of the protein, thereby excluding an inter-
mediate conformational exchange regime.
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